UM  > Institute of Chinese Medical Sciences
Residential Collegefalse
Status已發表Published
Structure-based repurposing of FDA-approved drugs as inhibitors of NEDD8-activating enzyme
Zhong H.-J.4; Liu L.-J.4; Chan D.S.-H.2; Wang H.-M.1; Chan P.W.H.3; Ma D.-L.2; Leung C.-H.4
2014
Source PublicationBiochimie
ISSN61831638 03009084
Volume102Issue:1Pages:211-215
Abstract

We report the discovery of an inhibitor of NEDD8-activating enzyme (NAE) by an integrated virtual screening approach. Piperacillin 1 inhibited NAE activity in cell-free and cell-based systems with high selectivity. Furthermore, piperacillin 1 was able to inhibit the degradation of the NAE downstream protein substrate p27. Our molecular modeling and kinetic studies suggested that this compound may act as a non-covalent ATP-competitive inhibitor of NAE.

KeywordInhibitor Nedd8-activating Enzyme Repurposing Structure-based Virtual Screening
DOI10.1016/j.biochi.2014.03.005
URLView the original
Indexed BySCIE
Language英語English
WOS Research AreaBiochemistry & Molecular Biology
WOS SubjectBiochemistry & Molecular Biology
WOS IDWOS:000338623600024
Scopus ID2-s2.0-84901791098
Fulltext Access
Citation statistics
Document TypeJournal article
CollectionInstitute of Chinese Medical Sciences
Corresponding AuthorMa D.-L.; Leung C.-H.
Affiliation1.Department of Fragrance and Cosmetic Science, Graduate Institute of Natural Products, Kaohsiung Medical University, Taiwan, ROC
2.Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China
3.Division of Chemistry and Biological Chemistry, School of Physical and Mathematical Sciences, Nanyang Technological University,Singapore 637371, Singapore
4.State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China
First Author AffilicationInstitute of Chinese Medical Sciences
Corresponding Author AffilicationInstitute of Chinese Medical Sciences
Recommended Citation
GB/T 7714
Zhong H.-J.,Liu L.-J.,Chan D.S.-H.,et al. Structure-based repurposing of FDA-approved drugs as inhibitors of NEDD8-activating enzyme[J]. Biochimie, 2014, 102(1), 211-215.
APA Zhong H.-J.., Liu L.-J.., Chan D.S.-H.., Wang H.-M.., Chan P.W.H.., Ma D.-L.., & Leung C.-H. (2014). Structure-based repurposing of FDA-approved drugs as inhibitors of NEDD8-activating enzyme. Biochimie, 102(1), 211-215.
MLA Zhong H.-J.,et al."Structure-based repurposing of FDA-approved drugs as inhibitors of NEDD8-activating enzyme".Biochimie 102.1(2014):211-215.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Zhong H.-J.]'s Articles
[Liu L.-J.]'s Articles
[Chan D.S.-H.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Zhong H.-J.]'s Articles
[Liu L.-J.]'s Articles
[Chan D.S.-H.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zhong H.-J.]'s Articles
[Liu L.-J.]'s Articles
[Chan D.S.-H.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.